HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alessandra Rubagotti Selected Research
Alessandra Rubagotti Research Topics
Disease
18
Neoplasms (Cancer)
09/2022 - 08/2002
18
Prostatic Neoplasms (Prostate Cancer)
07/2020 - 11/2002
15
Breast Neoplasms (Breast Cancer)
09/2022 - 05/2003
3
Mastodynia
11/2014 - 10/2005
2
Circulating Neoplastic Cells
07/2020 - 09/2019
2
Carcinogenesis
07/2015 - 03/2006
2
Gynecomastia
11/2014 - 10/2005
2
Urinary Bladder Neoplasms (Bladder Cancer)
01/2008 - 12/2006
2
Colorectal Neoplasms (Colorectal Cancer)
12/2006 - 08/2002
2
Endometrial Neoplasms (Endometrial Cancer)
12/2006 - 08/2005
1
Pain (Aches)
01/2018
1
Hypokalemia
01/2018
1
Testicular Neoplasms (Testicular Cancer)
10/2014
1
Urogenital Neoplasms
10/2014
1
Kidney Neoplasms (Kidney Cancer)
10/2014
1
Carcinoma (Carcinomatosis)
09/2011
1
Ovarian Epithelial Carcinoma
01/2005
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2004
1
Agranulocytosis (Granulocytopenia)
06/2004
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2004
1
Breast Cyst
05/2003
1
Cysts
05/2003
1
Disease Progression
11/2002
1
Aneuploidy (Aneuploid)
08/2002
Drug/Important Bio-Agent (IBA)
11
Proteins (Proteins, Gene)
FDA Link
09/2022 - 06/2003
6
Periostin
IBA
07/2020 - 12/2012
6
Tamoxifen
FDA Link
Generic
04/2011 - 08/2005
5
Androgens
IBA
01/2018 - 11/2002
5
bicalutamide (Casodex)
FDA Link
Generic
03/2013 - 11/2002
3
Androgen Receptors (Androgen Receptor)
IBA
09/2019 - 09/2011
3
Hormones (Hormone)
IBA
09/2019 - 12/2006
3
Nuclear Matrix-Associated Proteins
IBA
08/2012 - 06/2003
3
2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)
IBA
04/2012 - 05/2003
3
Aromatase Inhibitors
IBA
03/2007 - 10/2005
3
Anastrozole (Arimidex)
FDA Link
Generic
12/2006 - 08/2005
2
Abiraterone Acetate
IBA
09/2019 - 01/2018
2
Docetaxel (Taxotere)
FDA Link
09/2019 - 01/2018
2
Prednisone (Sone)
FDA Link
Generic
01/2018 - 01/2008
2
Androgen Antagonists (Antiandrogens)
IBA
11/2014 - 10/2005
2
Heterogeneous-Nuclear Ribonucleoprotein K
IBA
05/2014 - 09/2011
2
Lignans
IBA
04/2012 - 03/2006
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2010 - 06/2004
2
Estrogen Receptors
IBA
03/2007 - 08/2005
2
Pharmaceutical Preparations
IBA
12/2006 - 10/2005
1
Aspartic Acid (Aspartate)
FDA Link
09/2022
1
Mixed Function Oxygenases (Monooxygenases)
IBA
09/2022
1
Messenger RNA (mRNA)
IBA
07/2020
1
Extracellular Matrix Proteins
IBA
07/2020
1
Biological Products
IBA
01/2020
1
Phenobarbital (Luminal)
FDA Link
01/2020
1
apalutamide
IBA
09/2019
1
enzalutamide
IBA
09/2019
1
Prostate-Specific Antigen (Semenogelase)
IBA
01/2018
1
Angiotensin II
IBA
11/2015
1
Testosterone (Sustanon)
FDA Link
11/2014
1
Complement System Proteins (Complement)
IBA
06/2013
1
complement C3f
IBA
06/2013
1
Dihydrotestosterone (Androstanolone)
IBA
03/2013
1
afimoxifene (hydroxytamoxifen)
IBA
09/2011
1
imidazole mustard (BIC)
IBA
09/2011
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2010
1
Vinorelbine (Navelbine)
FDA Link
Generic
01/2010
1
Methotrexate (Mexate)
FDA Link
Generic
01/2010
1
Fluorouracil (Carac)
FDA Link
Generic
01/2010
1
Epirubicin (Ellence)
FDA Link
Generic
01/2010
1
Gefitinib (Iressa)
FDA Link
01/2008
1
Biomarkers (Surrogate Marker)
IBA
01/2008
1
Tyrosine Kinase Inhibitors
IBA
01/2008
1
ErbB Receptors (EGF Receptor)
IBA
01/2008
1
Cyclin D1
IBA
12/2006
1
Cell Cycle Proteins
IBA
12/2006
1
Lamin Type B (Lamin B)
IBA
03/2006
1
Lamins
IBA
03/2006
1
Estrogen Receptor Modulators (Antiestrogen)
IBA
10/2005
1
Oncogene Proteins (Oncogene Protein)
IBA
01/2005
1
Mitoxantrone (Novantrone)
FDA Link
Generic
06/2004
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
06/2004
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
06/2004
1
fludarabine
IBA
06/2004
1
Anti-Bacterial Agents (Antibiotics)
IBA
06/2004
1
Epidermal Growth Factor (EGF)
IBA
05/2003
1
Cations
IBA
05/2003
1
Flutamide (Eulexin)
FDA Link
Generic
11/2002
1
Goserelin (Zoladex)
FDA Link
11/2002
1
DAPI
IBA
08/2002
1
DNA (Deoxyribonucleic Acid)
IBA
08/2002
Therapy/Procedure
6
Therapeutics
01/2018 - 10/2005
5
Castration
07/2020 - 11/2002
2
Drug Therapy (Chemotherapy)
09/2015 - 04/2011
1
Radiotherapy
09/2019
1
Lasers (Laser)
11/2015
1
Adjuvant Chemotherapy
09/2015
1
Prostatectomy (Retropubic Prostatectomy)
06/2003